Publications by authors named "Erin Hertlein"

Claim this Profile
M
MYD88 mutations in clonal hematopoiesis promote inflammation and hematopoietic stem cell expansion.
Jennifer Yeung, Sophia Y Philbrook, Emma Uible, Lynn Lee, Kwangmin Choi, Erin Hertlein

bioRxiv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DHODH inhibition alters T cell metabolism limiting acute graft-versus-host disease while retaining graft-versus-leukemia response.
Rathan Kumar, Kara M Braunreiter, Lotus Neidemire-Colley, Natalie Sell, Yandi Gao, Erin K Hertlein

J Immunol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD37 in acute myeloid leukemia: a novel surface target for drug delivery.
Erin Jeremy, Esthela Artiga, Sara Elgamal, Carolyn Cheney, Dalen Eicher, Erin Hertlein

Blood Adv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiomic profiling identifies predictors of survival in African American patients with acute myeloid leukemia.
Andrew Stiff, Maarten Fornerod, Bailee N Kain, Deedra Nicolet, Benjamin J Kelly, Erin Hertlein

Nat Genet· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Mutation Clonal Hierarchy in Acute Myeloid Leukemia.
Sydney Fobare, Chia Sharpe, Kate Quinn, Kinsey Bryant, Linde A Miles, Erin Hertlein

bioRxiv· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrimidine depletion enhances targeted and immune therapy combinations in acute myeloid leukemia.
Ola A Elgamal, Sydney Fobare, Sandip Vibhute, Abeera Mehmood, Dennis C Vroom, Erin Hertlein

JCI Insight· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of Enhancer of Zeste Homolog 2 Induces Blast Differentiation, Impairs Engraftment and Prolongs Survival in Murine Models of Acute Myeloid Leukemia.
Sydney Fobare, Ola A Elgamal, Mark Wunderlich, Emily Stahl, Abeera Mehmood, Erin Hertlein

Cancers (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia: Alliance for Clinical Trials in Oncology study.
Bhavana Bhatnagar, Jessica Kohlschmidt, Shelley J Orwick, Daelynn R Buelow, Sydney Fobare, Erin K Hertlein

Blood Adv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mass Cytometry as a Tool for Investigating Senescence in Multiple Model Systems.
Amina Abdul-Aziz, Raymond D Devine, Justin M Lyberger, Hsiaochi Chang, Amy Kovacs, Erin Hertlein

Cells· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with Mutation/Deletion.
Eric D Eisenmann, Jack C Stromatt, Sydney Fobare, Kevin M Huang, Daelynn R Buelow, Erin Hertlein

Cancers (Basel)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA Origami Nanostructures Elicit Dose-Dependent Immunogenicity and Are Nontoxic up to High Doses In Vivo.
Christopher R Lucas, Patrick D Halley, Amjad A Chowdury, Bonnie K Harrington, Larry Beaver, Erin K Hertlein

Small· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PP2A is a therapeutically targetable driver of cell fate decisions via a c-Myc/p21 axis in human and murine acute myeloid leukemia.
Swagata Goswami, Rajeswaran Mani, Jessica Nunes, Chi-Ling Chiang, Kevan Zapolnik, Erin Hertlein

Blood· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular, clinical, and prognostic implications of PTPN11 mutations in acute myeloid leukemia.
Sydney Fobare, Jessica Kohlschmidt, Hatice Gulcin Ozer, Krzysztof Mrózek, Deedra Nicolet, Erin Hertlein

Blood Adv· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significance of chromosome 2p gain in ibrutinib-treated chronic lymphocytic leukemia patients.
Cecelia R Miller, Ying Huang, Amy S Ruppert, Jadwiga Labanowska, Samantha M Jaglowski, Erin K Hertlein

Leukemia· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of the Hsp90 inhibitor SNX-5422 in ibrutinib resistant CLL.
Timothy L Chen, Bonnie Harrington, Jean Truxall, Ronni Wasmuth, Alexander Prouty, Erin Hertlein

J Hematol Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TP-0903 is active in models of drug-resistant acute myeloid leukemia.
Jae Yoon Jeon, Daelynn R Buelow, Dominique A Garrison, Mingshan Niu, Eric D Eisenmann, Erin Hertlein

JCI Insight· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical efficacy for a novel tyrosine kinase inhibitor, ArQule 531 against acute myeloid leukemia.
Ola A Elgamal, Abeera Mehmood, Jae Yoon Jeon, Bridget Carmichael, Amy Lehman, Erin Hertlein

J Hematol Oncol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leukemic B Cell CTLA-4 Suppresses Costimulation of T Cells.
Priscilla Do, Kyle A Beckwith, Carolyn Cheney, Minh Tran, Larry Beaver, Erin Hertlein

J Immunol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-BAFF-R antibody VAY-736 demonstrates promising preclinical activity in CLL and enhances effectiveness of ibrutinib.
Emily M McWilliams, Christopher R Lucas, Timothy Chen, Bonnie K Harrington, Ronni Wasmuth, Erin Hertlein

Blood Adv· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Near-tetraploidy is associated with Richter transformation in chronic lymphocytic leukemia patients receiving ibrutinib.
Cecelia R Miller, Amy S Ruppert, Nyla A Heerema, Kami J Maddocks, Jadwiga Labanowska, Erin K Hertlein

Blood Adv· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NF-κB p50 () contributes to pathogenesis in the Eμ-TCL1 mouse model of chronic lymphocytic leukemia.
Timothy L Chen, Minh Tran, Aparna Lakshmanan, Bonnie K Harrington, Nikhil Gupta, Erin Hertlein

Blood· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The long noncoding RNA, treRNA, decreases DNA damage and is associated with poor response to chemotherapy in chronic lymphocytic leukemia.
Cecelia R Miller, Amy S Ruppert, Sydney Fobare, Timothy L Chen, Chaomei Liu, Erin K Hertlein

Oncotarget· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial of the intravenous Hsp90 inhibitor alvespimycin (17-DMAG) in patients with relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma.
Kami Maddocks, Erin Hertlein, Timothy L Chen, Amy J Wagner, Yonghua Ling

Leuk Lymphoma· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide Induces Interleukin-21 Production by T Cells and Enhances IL21-Mediated Cytotoxicity in Chronic Lymphocytic Leukemia B Cells.
Rebekah L Browning, William H Byrd, Nikhil Gupta, Jeffrey Jones, Xiaokui Mo, Erin Hertlein

Cancer Immunol Res· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hsp90 inhibition increases SOCS3 transcript and regulates migration and cell death in chronic lymphocytic leukemia.
Timothy L Chen, Nikhil Gupta, Amy Lehman, Amy S Ruppert, Lianbo Yu, Erin Hertlein

Oncotarget· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis